早发性卵巢功能不全的发病率及相关因素:基于人群的队列研究
该研究基于加拿大安大略省1995至2019年≤39岁女性行政健康数据,估算早发性卵巢功能不全(POI)发病率并分析相关因素。共纳入3 635 702名女性,168 173例发生POI,总发病率为389.4/10万人年;2011年后发病率上升,主要由非医源性POI驱动,子宫内膜异位症者发病率最高。
要点
- POI总发病率为389.4/10万人年,诊断中位年龄31岁。
- 2011年后POI发病率持续上升,主要归因于非医源性POI。
- 子宫内膜异位症与POI风险升高相关(IRR 3.45,95% CI 3.39,3.52)。
核心结论
- 安大略省1995至2019年POI发病率在2011年后上升,主要由非医源性POI驱动,子宫内膜异位症者发病率最高。
研究设计与样本
- 基于人群的队列研究,纳入1995至2019年居住在安大略省的所有≤39岁女性,共3 635 702名。
- 随访至POI诊断、年满40岁、死亡、失去省医疗保险或研究期结束,中位随访11年(IQR 6-18)。
- POI定义为40岁前诊断,依据行政健康数据:手术性绝经,或≥1次编码为绝经(ICD-9 627)的医生咨询。
主要发现
- 168 173名女性发生任何病因的POI,发病率389.4/10万人年,诊断中位年龄31岁(IQR 25-36)。
- 非医源性POI发病率351.4/10万人年,手术性30.2,化疗和/或放疗后5.5,手术联合化疗和/或放疗2.3(均每10万人年)。
- 总体POI发病率2002至2008年下降,之后持续上升至2019年,主要归因于非医源性POI。
- 手术性POI发病率从1995年60/10万人年降至2019年20/10万人年;手术联合化疗和/或放疗POI在研究期间稳步上升。
关键数值与推荐
- 子宫内膜异位症IRR 3.45(95% CI 3.39,3.52)。
- 接受化疗或放疗的癌症IRR 2.01(95% CI 1.89,2.14)。
- 药物或烟草使用IRR 1.59(95% CI 1.51,1.67)。
- 染色体疾病IRR 1.50(95% CI 1.42,1.59)。
- 自身免疫性疾病IRR 1.19(95% CI 1.17,1.22)。
临床怎么用
- 应关注子宫内膜异位症女性的POI风险,加强风险分层与咨询。
- 手术性POI发病率下降提示卵巢保留手术方式的应用增加。
- 非医源性POI发病率上升,需进一步研究其机制与可干预危险因素。
局限性
- 使用行政健康数据可能导致结局错分,且临床与人口学详细信息有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the incidence of premature ovarian insufficiency (POI) and its associated factors in Ontario, Canada, between 1995 and 2019? SUMMARY ANSWER: The incidence of POI increased after 2011, driven primarily by non-iatrogenic POI, and was highest among women with a history of endometriosis. WHAT IS KNOWN ALREADY: Recent estimates suggest a global POI prevalence of ∼3.7%, with increasing rates over time. POI has heterogeneous etiologies, including genetic, autoimmune, infectious, and iatrogenic causes; however, the cause remains unknown in ∼70% of non-iatrogenic cases. Existing incidence estimates are limited by recall bias, cross-sectional designs, small sample sizes, and limited assessment of associated factors. STUDY DESIGN, SIZE, DURATION: This population-based cohort study included all women aged ≤ 39 years residing in Ontario between 1995 and 2019. Follow-up continued until POI diagnosis, age 40 years, death, loss of provincial health insurance, or end of the study period. PARTICIPANTS/MATERIALS, SETTING, METHODS: POI was defined using administrative health data as a diagnosis occurring before age 40 years identified by either (i) surgical menopause or (ii) ≥1 physician consultation coded as menopause (ICD-9 627). Annual incidence rates (IRs) were calculated using census data, with the Ontario female population aged ≤ 39 years as the denominator. POI was classified as non-iatrogenic, surgical, post-chemotherapy and/or radiotherapy, or combined surgical with chemotherapy and/or radiotherapy. Associations between clinical factors and POI were estimated using age-adjusted modified Poisson regression to derive incidence rate ratios (IRRs). MAIN RESULTS AND THE ROLE OF CHANCE: Among 3 635 702 eligible women, 168 173 developed POI from any etiology (IR 389.4 per 100 000 person-years). Median follow-up was 11 years (IQR 6-18), and median age at POI diagnosis was 31 years (IQR 25-36). IRs were 351.4 per 100 000 person-years for non-iatrogenic POI, 30.2 for surgical POI, 5.5 for post-chemotherapy and/or radiotherapy POI, and 2.3 for combined surgical with chemotherapy and/or radiotherapy POI. Overall POI incidence declined between 2002 and 2008, followed by a sustained increase through 2019, largely attributable to non-iatrogenic POI. The incidence of surgically induced POI decreased from 60 per 100 000 person-years in 1995 to 20 in 2019, while combined surgical with chemotherapy and/or radiotherapy POI increased steadily over the study period. Factors associated with higher POI incidence included endometriosis (IRR 3.45, 95% CI 3.39, 3.52), cancer treated with chemotherapy or radiotherapy (IRR 2.01, 95% CI 1.89, 2.14), drug or tobacco use (IRR 1.59, 95% CI 1.51, 1.67), chromosomal disorders (IRR 1.50, 95% CI 1.42, 1.59), and autoimmune diseases (IRR 1.19, 95% CI 1.17, 1.22). LIMITATIONS, REASONS FOR CAUTION: Use of administrative health data may result in outcome misclassification and limited availability of detailed clinical and demographic information. WIDER IMPLICATIONS OF THE FINDINGS: These findings provide contemporary population-based estimates of POI incidence and identify endometriosis as a major associated factor. The marked decline in surgically induced POI over time suggests increased adoption of ovarian-preserving surgical approaches, while rising non-iatrogenic POI incidence underscores the need for improved risk stratification, counselling, and further studies to elucidate underlying mechanisms and modifiable risk factors. FUNDING: Canadian Menopause Society. DISCLOSURES: Nothing to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Macintyre JN, Pudwell J, Shellenberger J, et al. Incidence and factors associated with premature ovarian insufficiency: a population-based cohort study. Hum Reprod. 2026. PMID: 42449546. doi:10.1093/humrep/deag111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。